The existence of a local cardiovascular renin-angiotensin system (RAS) is often invoked to explain the long-term beneficial effects of RAS inhibitors in heart failure and hypertension. The implicit assumption is that all components of the RAS are synthesized in situ, so that local angiotensin II formation may occur independently of the circulating RAS. Evidence for this assumption however is lacking. The angiotensin release from isolated perfused rat hearts or hindlimbs depends on the presence of renal renin. When calculating the in vivo angiotensin production at tissue sites in humans and pigs, taking into account the extensive regional angiotensin clearance by infusing radiolabeled angiotensin I or II, it was found that angiotensin production correlated closely with plasma renin activity. Moreover, in pigs the cardiac tissue levels of renin and angiotensin were directly correlated with their respective plasma levels, and both in tissue and plasma the levels were undetectably low after nephrectomy. Similarly, rat vascular renin and angiotensin decrease to low or undetectable levels within 48 h after nephrectomy. Aortic renin has a longer half life than plasma renin, suggesting that renin may be bound by the vessel wall. In support of this assumption, both renin receptors and renin-binding proteins have been described. Like ACE, renin was enriched in a purified membrane fraction prepared from cardiac tissue. Binding ofrenin to cardiac or vascular membranes may therefore be part of a mechanism by which renin is taken up from plasma. It appears that the concept of a local RAS needs to be reassessed. Local angiotensin formation in heart and vessel wall does occur, but depends, at least under normal circumstances, on the uptake of renal renin from the circulation. Tissues may regulate their local angiotensin concentrations by varying the number of renin receptors and/or renin-binding proteins, the ACE level, the amount of metabolizing enzymes and the angiotensin receptor density. (Mol Cell Biochem 157" 211-216, 1996) 
Introduction
The renin-angiotensin system (RAS) plays an important role in the regulation of blood pressure and body fluid volumes. According to the classical concept, liver-derived angiotensinogen is cleaved in the circulating blood by renin from the kidneys, to form angiotensin (ANG) I. ANG I is then converted to ANG II, a potent vasoconstrictor and stimulant of the release ofaldosterone, by angiotensin-converting enzyme (ACE) located on the luminal side of the vascular endothelium. Recent evidence suggests that angiotensins are not only produced in the circulation, but also at tissue sites (Fig. l) . All components of the RAS have been demonstrated in a number of tissues, for instance the heart, adrenal, brain, vessel wall, ovary and testis. Based on these findings it has been proposed that so-called local or tissue renin-angiotensin systems exist, as opposed to the circulating RAS. However, the question whether all tissue RAS components are truly synthesized locally or whether they are taken up from the circulation ( Fig. 1) has not yet been answered satisfactorily.
Blockers of the RAS, the ACE inhibitors in particular, are now widely used for the treatment of hypertension and heart failure. The beneficial effects of these drugs are not yet completely understood. One important aspect may be the inhibition of angiotensin synthesis in heart and vessel wall. Therefore, by unraveling the precise mechanisms underly- 
Definition of a local RAS
What is meant when using the term 'local RAS'? One or more of the following three situations may exist: 1) the RAS components required for ANG II synthesis, i.e. renin, angiotensinogen and ACE, are synthesized in situ, thus a!lowing local ANG II generation to occur independently of the circulating RAS; 2) the RAS components required for ANG II synthesis are not synthesized in situ, but taken up from the circulating blood, thus allowing local ANG II synthesis to occur only when RAS components are available in the blood; 3) a combination of 1) and 2).
When applying definition 2 or 3, one no longer considers in situ synthesis of renin of importance, so that, at least in theory, one should better speak of a system generating ANG II locally in stead of a local RAS.
Local angiotensin production
Local production of angiotensins has been investigated extensively, both through in vivo and in vitro studies. However, from these studies it is difficult to conclude whether angiotensin is produced locally by locally synthesized components, by blood-borne components of the RAS which have been taken up from the circulation, or by a combination of these two. In studies performed in vitro, isolated organs or vessels are perfused with a buffered solution and 'local' angiotensin generation is calculated from the levels of ANG I and II in the perfusate. In this setup, the isolated rat heart was not found to release any measurable quantities of ANG I or II, unless renin was added to the perfusion buffer [1] . This suggests that angiotensinogen and ACE, but not renin, are present in the isolated rat heart. Isolated perfused rat hindlimbs do release ANG I and II spontaneously [2, 3] . ACE inhibition with captopril abolished hindlimb ANG II release while ANG I levels in the perfusate increased more than tenfold [2] . The addition ofrenin to the perfusate significantly increased the ANG I and II release by rat hindlimbs [2, 3] . Moreover, the angiotensin release remained elevated for 1 h after stopping the renin infusion, suggesting that some infused renin was sequestered by the vessel wall [3] . Angiotensin release by isolated rat hindlimbs correlated with the renin levels measured in plasma prior to the experiment: it was increased in rats with a stimulated plasma RAS (treated with either the angiotensin AT 1 receptor antagonist losartan or a diuretic) and decreased in nephrectomized rats, where the plasma RAS is down to almost undetectable levels [3] . This suggests that plasma renin of renal origin is the major source of vascular renin. Remarkably, the amount of ANG II in the perfusate of isolated hindlimbs is usually higher than the amount ofANG I [2, 3] . This contrasts with the situation in plasma, where ANG I is higher than ANG II [4, 5] . However, it is in accordance with studies in tissues, where ANG II levels are higher than ANG I levels [6, 7] . Thus, the reversed ANG II/I ratio in hindlimb perfusate as compared to plasma may truly reflect angiotensin generation at tissue sites.
The simplest approach to investigate local angiotensin generation in vivo (in whole animals), is to measure the arteriovenous difference for ANG I or II across a certain vascular bed and to multiply this difference with the regional flow. One has to be careful with the interpretation of the results from such studies, since angiotensins can also be generated in the blood flowing through the vascular bed. In addition, angiotensins are metabolized extensively at tissue sites, which, when not taken into account, would lead to an underestimation of local angiotensin production. A more precise approach for in vivo studies would therefore be to correct for angiotensin generation in the blood and for local angiotensin metabolism, by measuring plasma renin activity (PRA) and regional angiotensin clearance, respectively. The latter has been done in early studies by giving ANG I and II infusions in sheep [8] . From the difference in arteriovenous gradients prior and during angiotensin infusion it could be predicted that a major part of venous ANG I and II must have been produced at tissue sites.
More recently, the regional metabolism and production of ANG I and II was quantified, both in humans and in pigs, by giving constant infusions ofradiolabeled 125I-ANG I or II [4, 5, [9] [10] [11] . Blood samples were taken under steady-state conditions from various arterial and venous sampling sites for the measurement of both endogenous and radiolabeled ANG I and II. From the levels of the endogenous and the labeled peptides the degree of regional metabolism of ANG I and II as well as the amount ofANG I and II that is generated in a vascular bed could be calculated. Additional measurements of PRA and calculations of the regional conversion of 125I-ANG I to ~25I-ANG II made it possible to calculate the amount of locally generated ANG I that can be attributed to PRA and the amount of locally generated ANG II that can be accounted for by the regional conversion of arterially delivered ANG I. The tissues that were included in these studies were heart, head, kidney, lung, liver/gut, skeletal muscle and skin. It was found that in all systemic vascular beds under study, venous ANG I could not be accounted for by arterial delivery of ANG I, by PRA, or by a combination of these two. A high percentage of venous ANG I must therefore have been produced locally, i.e. not in the circulating plasma. Only in the lungs local ANG I production could be attributed fully to PRA [9] . For ANG II, the situation appeared to be more complicated. Although it could be calculated that ANG II production at tissue sites did occur [9] , blood-borne ANG I was the main source of circulating ANG II [1 1]. These results illustrate the high degree of compartmentalization ofANG I and II production.
The local ANG i production measured in the above studies correlated strongly with PRA ( Fig. 2] , suggesting that most of the renin responsible for local ANG I production is kidney-derived. The same conclusion was reached by Taddei et al., who measured the forearm arteriovenous difference for renin, ANG I and II in man in the presence of increasing doses of the beta-adrenergic receptor stimulant isoproterenol [ 1 2] . Isoproterenol, when infused in the brachial artery, increased net forearm balance for renin and ANG I and II dose-dependently. However, the increase was transient and correlated with the levels of renin in plasma. Thus, it was concluded that vascular tissue renin originates from uptake from plasma. 
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PRA (fmol ANC I /ml.mln) Fig. 2 . Relationship between plasma renin activity (PRA) and cardiac angiotensin (ANG) I production in untreated, captopril-treated and furosemide-treated pigs.
213

Tissue levels of RAS components
Measurements ofrenin in vascular tissue before and after nephrectomy have shown that most or all of the renin-like activity in the vessel wall is derived from plasma renin [13, 14] . Aortic renin-like activity has a longer half life than plasma renin, suggesting that renin may be bound by the vessel wall [14] . A recent report suggests that vascular renin is predominantly present in the endothelial layer [15] . ACE can be detected both at endothelial and extra-endothelial sites [16] . Aortic ANG II levels are higher than plasma ANG II levels and decrease by more than 75% within 48 h after nephrectomy [7] .
Renin mRNA in cardiac tissue is either present in very low concentrations or absent entirely [ 17, 18] . We compared the tissue levels of RAS components in the heart with the levels in blood plasma in healthy and in nephrectomized pigs [6] . ANG I generating activity of cardiac tissue was identified as renin by its inhibition with a specific active site-directed renin inhibitor. Precautions were taken to prevent the ex vivo generation and breakdown of cardiac angiotensins, and appropriate corrections were made for any losses of intact ANG I and II during extraction and assay.
Tissue levels ofrenin and ANG I and II in the left and right atria were higher than in the corresponding ventricles. Cardiac renin and ANG I levels (expressed per g wet weight) were similar to the plasma levels, and ANG II in cardiac tissue was higher than in plasma. The presence of these RAS components in cardiac tissue therefore cannot be accounted for by trapped plasma or simple diffusion from plasma into the interstitial fluid. Angiotensinogen levels in cardiac tissue were 10-25% of the levels in plasma, which is compatible with its diffusion from plasma into the interstitium. Like ACE, renin was enriched in a purified cardiac membrane fraction prepared from left ventricular tissue, as compared to crude homogenate. Moreover, cardiac membranes were capable of binding added renin [ 1 9] .
Cardiac tissue levels ofrenin and ANG I and II, but not of angiotensinogen, were directly correlated with their respective plasma levels (Fig. 3) , and both in tissue and plasma the levels were undetectably low after bilateral nephrectomy. It appears therefore that 1) most, if not all, renin in cardiac tissue originates from the kidney, and 2) that cardiac angiotensin generation depends on renin.
These results support the contention that in the healthy heart, angiotensin production depends on plasma-derived renin, and that plasma-derived angiotensinogen in the interstitial fluid is a potential source &cardiac angiotensins. Binding of renin to cardiac membranes may be part of a mechanism by which renin is taken up from plasma. In support of this conclusion, studies in which bolus injections of radiolabeled renin were given to monkeys or rats showed that radioactivity accumulated not only in liver and kidney but also, albeit in lower amounts, in heart and blood vessels [20, 21 ] . Fig. 3 . Relationship between left ventricular tissue levels and plasma levels of angiotensin I (ANG I), angiotensin II (ANG II), renin and angiotensinogen in normal pigs.
Conclusion
The existence of a so-called local RAS in heart and vessel wall is still controversial. All RAS components are present in cardiac and vascular tissue and angiotensins are indeed produced in these tissues and subsequently released into the circulation. However, the renin responsible for this local angiotensin production, at least under normal circumstances, appears to be taken up from the circulation and is therefore kidney-derived. Thus, a local RAS in the sense that all RAS components necessary for ANG II production are synthesized in situ does not appear to exist in either heart or vessel wall. Local ANG II production in these tissues depends on uptake of renal renin from the circulation. Membrane-binding may be a mechanism by which renin is sequestered from the circulation. Both a renin receptor and a renin-binding protein have been described in various organs, including the heart [22, 23] .
Since renin in human arteries has been described to be limited mainly to the endothelial layer [ 15] , angiotensin synthesis may occur predominantly at the interphase between blood and tissue (Fig. 4) . Renin, bound to endothelial cells, will cleave angiotensinogen to generate ANG I. Endothelial ACE then rapidly converts ANG I into ANG II, and this ANG II may either enter the tissue (e.g. via receptor binding or intercellular junctions) or the vascular space. Alternatively, degrading enzymes can rapidly metabolize ANG II. At present it is not known whether other cells than endothelial cells, e.g. cardiac myocytes, are also capable of binding renin.
If the renin responsible for local angiotensin production is not produced locally but derived from the kidneys, one could conclude that tissue angiotensin production is in fact regulated by the kidneys. However, there are still may ways by which tissues may regulate their own ANG lI production. The number ofrenin receptors or renin-binding proteins may vary from tissue to tissue. Local renin synthesis might even occur under certain pathological conditions [24] . The availability of angiotensinogen is of importance, as is the amount of locally synthesized ACE. Tissue ACE levels are in part ge- netically determined [25] . Furthermore, degrading enzymes and ANG II receptors will regulate how much of the locally synthesized ANG II will enter the tissue. Blockers of the RAS may interfere with many of these local mechanisms by which the local ANG II concentrations are eventually determined.
